WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004003182) HOMOZYGOUS STEM CELLS ISOLATED FROM PATHOGENIC OOCYTES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/003182    International Application No.:    PCT/US2003/019986
Publication Date: 08.01.2004 International Filing Date: 26.06.2003
Chapter 2 Demand Filed:    26.01.2004    
IPC:
C12N 5/0735 (2010.01)
Applicants: STEMRON, INC. [US/US]; P.O. Box 269, Myersville, MD 21773 (US)
Inventors: YAN, Wen, Liang; (US).
HUANG, Steve Chien-Wen; (US).
NGUYEN, Minh-Thanh; (US).
LIN, Hua (Helen); (US).
LEI, Jingqi; (US).
KHANNA, Ruchi; (US)
Agent: HERBERT, Toni-Junel; Reed Smith LLP, Suite 1100 - East Tower, 1301 K Street, N.W., Washington, DC 20005 (US)
Priority Data:
10/179,959 26.06.2002 US
Title (EN) HOMOZYGOUS STEM CELLS ISOLATED FROM PATHOGENIC OOCYTES
(FR) CELLULES SOUCHES HOMOZYGOTES ISOLEES, CELLULES DIFFERENCIEES DERIVEES DE CES CELLULES ET MATERIAUX ET PROCEDES D'OBTENTION ET D'UTILISATION CORRESPONDANTS
Abstract: front page image
(EN)The present invention discloses ans describes pluripotent homozygous stem (HS) cells, and methods and materials for making same. The present invention also provides methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-relates disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.
(FR)L'invention concerne des cellules souches homozygotes (HS) myéloïdes ainsi que des procédés et des matériaux d'obtention de ces cellules. L'invention concerne également des procédés de différentiation de cellules HS dans des cellules de progéniteur (myéloïde) ou d'autres cellules, groupes de cellules ou tissus voulus. Par ailleurs, l'invention concerne des applications desdites cellules HS qui impliquent (sans caractère limitatif) le diagnostic et le traitement de différentes maladies (par exemple, les maladies génétiques, les maladies neurodégénératives, les troubles endocriniens connexes et le cancer), les lésions traumatiques, les transplantations esthétiques ou thérapeutiques, la thérapie génique et la thérapie de remplacement cellulaire.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)